Insider Activity of Gamelin Erick
According to the SEC Form 4 filings, Gamelin Erick, being in a position of
- Chief Development Officer at Acrivon Therapeutics, Inc. Common Stock,оver the last 12 months, has bought 0 shares, and sold 400 shares for $804,over all time since 2026-08-18, has bought 0 shares, and sold 400 shares for $804.
Biography of Gamelin Erick
No biography is available at this moment.